We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Access expired on Monday, January 7, 2019

This content was originally shared by a registered user, but access has expired. Create a free account to gain permanent access to all PracticeUpdate content.

Already Have An Account? Log in Now

featured
Published in Dermatology

Journal Scan / Research · December 05, 2018

Antinuclear Antibody Status, Clinical Features, and Malignancy Risk in Adult-Onset Dermatomyositis

Journal of the American Academy of Dermatology

 

Additional Info

Journal of the American Academy of Dermatology
Association of Antinuclear Antibody Status With Clinical Features and Malignancy Risk in Adult-Onset Dermatomyositis
J Am Acad Dermatol 2018 Nov 17;[EPub Ahead of Print], PM Hoesly, JC Sluzevich, A Jambusaria-Pahlajani, ER Lesser, MG Heckman, A Abril

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.